Providing effective support in acute care settings means your equipment must perform fast and flawlessly. Our VITROS™ assay menu, coupled with our built-in intelligent technologies, offers a full STAT menu and unique assays for the ICU and emergency departments. This gives clinicians the confidence to make fast, effective treatment decisions.
Quality systems from start to finish
VITROS™ systems are always ready with no standby mode, priming, washes or reagent hydration.
Delivers real-time process monitoring, including sample indices, with fully documented traceability to protect result integrity and minimize workflow disruptions. Provides smooth, effortless and transparent reporting of diagnostic checks throughout sample and assay processing.
Our VALUMETRIX™ Consulting Services use lean-powered methodology to identify, reduce and eliminate non-value tasks that delay the delivery of results and patient care. Regular ValuCheckSM Services allow for continuous quality improvements into the future.
Effective lab management is all about continuous quality improvement – of your staff, your processes and your results – while reducing costs, equipping your lab for future growth and meeting patients’ needs. Automation can help. Versatile, effective and reliable VITROS Automation Solutions combined with VITROS Chemistry and Immunoassay Systems deliver high-quality results – faster than VITROS Systems alone – and your clinicians will notice the difference.
VITROS™ Cardiac Testing: Fast, accurate results for patients who can’t afford to wait
When time is short and critical decisions need to be made, we help you provide fast, accurate results that clinicians can rely on. Our comprehensive assay menu for the diagnosis and management of acute coronary events and heart failure provides the tests you can rely on.
Ready to get started?
Sepsis: When early diagnosis can mean better patient outcomes
Early confirmation of bacterial infection increases a patient’s chance for survival.* Our sepsis assay menu provides reliable and high-quality results proven by Six Sigma designations,** so you can trust them to help inform the best treatment decisions and support your institution’s antibiotic stewardship initiatives.
*Kim HI, Park S. Sepsis: Early recognition and optimized treatment. Tuberc Respir Dis (Seoul). 2019;82(1):6-14. doi:10.4046/trd.2018.0041
**Per competitive Six Sigma published data
Ready to get started?
Built-in intelligent technologies enable accuracy and efficiency
Our dry-format MicroSlides enables robust performance, filters out common interferences and provides industry-leading calibration stability.*
*Stability claim based on publicly available data for select competitive systems. Data on file.
Our MicroSensor technology automates detection of HIT interferences on every sample in less than one second, without the use of any additional sample or reagent.
Our proprietary, enhanced chemiluminescence detection technology provides exceptional immunoassay precision for wide dynamic ranges across a broad test menu and disease states.
D = In development/currently not available.
* MicroTip Partnership Assay (MPA); Reagents and validated applications available directly from QuidelOrtho.
Related Products
